With 23andMe in ‘financial distress,’ California official issues alert to customers
By Jason Green,
The Mercury News
| 03. 24. 2025
With genetic testing company 23andMe facing an increasingly uncertain future, California Attorney General Rob Bonta on Friday reminded customers they have the right to tell the firm to permanently delete their data.
The South San Francisco-based company has publicly reported it is in “financial distress” and stated in recent securities filings that there is substantial doubt about its ability to keep going, the California Attorney General’s Office said in a news release.
The “trove of sensitive consumer data” amassed by 23andMe is subject to deletion under both the Genetic Information Privacy Act and the California Consumer Protection Act, according to the office.
“California has robust privacy laws that allow consumers to take control and request that a company delete their genetic data,” Bonta said in a statement. “Given 23andMe’s reported financial distress, I remind Californians to consider invoking their rights and directing 23andMe to delete their data and destroy any samples of genetic material held by the company.”
Customers can delete their 23andMe account and personal information by taking the following steps:
- Log into your 23andMe account on the...
Related Articles
By Darren Incorvaia, Fierce Biotech | 07.16.2026
Jennifer Doudna, Ph.D., the Nobel Laureate best known for co-inventing the CRISPR system that has become the foundation for gene editing, is dipping her toes into a new, buzzy field: AI-powered protein design.
In a new paper, published today...
By Risa Cromer, The Conversation | 07.17.2026
By Emily Packard Dawson and Lainie Friedman Ross , The Hastings Center for Bioethics | 07.16.2026
Major news outlets recently reported – based on a bioRxiv preprint – that scientists had edited genes in human embryos with “startling precision.” The scientists’ decision to release this work ahead of peer review, coupled with the extensive media coverage...
Media coverage of recent developments in embryo gene editing might seem to suggest that gene-edited babies are close to becoming a reality. As tech billionaires eager to profit off of techno-eugenics invest in “designer baby” technologies, attempts to normalize heritable genome editing – which remains unsafe and raises significant ethical and societal concerns – are especially dangerous. It’s worth taking a closer look at these developments and what they mean, in a way that pushes back on narratives normalizing the...
